Report overview
This report contains market size and forecasts of Recombinant Coagulation Factor IX in global, including the following market information:
Global Recombinant Coagulation Factor IX Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Coagulation Factor IX Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Recombinant Coagulation Factor IX companies in 2021 (%)
The global Recombinant Coagulation Factor IX market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
500 IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Coagulation Factor IX include Pfizer, Rebinyn, CSL Behring, Takeda, Sanofi, Aptevo Bio Therapeutics and Thermo Fisher, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Coagulation Factor IX manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Coagulation Factor IX Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor IX Market Segment Percentages, by Type, 2021 (%)
500 IU
1000 IU
Other
Global Recombinant Coagulation Factor IX Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor IX Market Segment Percentages, by Application, 2021 (%)
Adult
Children
Global Recombinant Coagulation Factor IX Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor IX Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Coagulation Factor IX revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Coagulation Factor IX revenues share in global market, 2021 (%)
Key companies Recombinant Coagulation Factor IX sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Recombinant Coagulation Factor IX sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Rebinyn
CSL Behring
Takeda
Sanofi
Aptevo Bio Therapeutics
Thermo Fisher
